IBM · NYSE
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $67.53B | $62.75B | $61.86B | $60.53B | $57.35B | $55.18B | $57.71B | $79.59B |
| Cost of Revenue | $28.24B | $27.20B | $27.56B | $27.84B | $25.86B | $24.31B | $26.18B | $42.66B |
| Gross Profit | $39.30B | $35.55B | $34.30B | $32.69B | $31.49B | $30.86B | $31.53B | $36.94B |
| Research & Development | $8.32B | $7.48B | $6.78B | $6.57B | $6.49B | $6.26B | $5.91B | $5.38B |
| Selling, General & Administrative | $20.12B | $19.69B | $19.00B | $18.61B | $18.75B | $20.56B | $18.72B | $19.37B |
| Interest Expense | $1.94B | $1.71B | $1.61B | $1.22B | $1.16B | $1.29B | $1.34B | $723.00M |
| Other Income / (Expense) | $221.00M | $877.00M | $266.00M | $443.00M | $225.00M | $156.00M | — | — |
| Income Before Taxes | $10.33B | $5.80B | $8.69B | $1.16B | $4.84B | $2.57B | $7.21B | $11.34B |
| Provision for Income Taxes | -$242.00M | -$218.00M | $1.18B | -$626.00M | $124.00M | -$1.36B | $60.00M | $2.62B |
| Net Income | $10.59B | $6.02B | $7.50B | $1.64B | $5.74B | $5.59B | $9.43B | $8.73B |
| Basic EPS | $11.36 | $6.53 | $8.23 | $1.82 | $6.41 | $6.28 | $10.63 | $9.57 |
| Diluted EPS | $11.17 | $6.43 | $8.14 | $1.80 | $6.35 | $6.23 | $10.56 | $9.52 |
| Basic Shares Outstanding | 932.29M | 921.77M | 911.21M | 902.66M | 895.99M | 890.35M | 887.24M | 912.05M |
| Diluted Shares Outstanding | 948.68M | 937.16M | 922.07M | 912.27M | 904.64M | 896.56M | 892.81M | 916.32M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Dec 2026 | $12.34 | $12.08 | $12.63 | 8 | ↑4 ↓3 |
| Dec 2027 | $13.23 | $12.69 | $13.86 | 9 | ↑2 ↓5 |
| Dec 2028 | $14.26 | $14.13 | $14.44 | 3 | ↑0 ↓0 |
| Dec 2029 | $15.34 | $15.34 | $15.34 | 1 | ↑0 ↓0 |